Innovations in siRNA research: A technology comes of age

Recent Patents on Anti-Infective Drug Discovery

Volumn 5, Issue 3, 2010, Pages 226-239

  Hefferon, Kathleen L ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Human disease; Liposomes; Nanocarriers; Plant sciences; RNA interference; Short interfering RNA; siRNA; Viral and nonviral delivery vehicles

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; APTAMER; CHOLESTEROL; DOUBLE STRANDED DNA; IMMUNOGLOBULIN F(AB) FRAGMENT; LENTIVIRUS VECTOR; NANOCARRIER; NANOPARTICLE; RNA; SINGLE STRANDED DNA; SMALL INTERFERING RNA;

ARTICLE; BIOSAFETY; CANCER THERAPY; CELLULAR IMMUNITY; DEGENERATIVE DISEASE; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RNA DEGRADATION; RNA INTERFERENCE; SIRNA TECHNOLOGY; TARGET CELL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS REPLICATION;

ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; PATENTS AS TOPIC; RNA, SMALL INTERFERING;

EID: 78649982120     PISSN: 1574891X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489110793348794     Document Type: Article

References (48)

1. Hamilton A, Baulcombe D. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 1999; 286 (5441): 950-2.
2. Fire A, Xu S, Montgomery M, Kostas S, Driver S, Mello C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391 (6669): 806-11.
3. Elbashir S, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411 (6836): 494-988.
4. Hannon G, Rossi J. Unlocking the potential of the human genome with RNA interference. Nature 2004; 431 (7006): 371-8.
5. Elbashir S, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001; 15 (2): 188-200.
6. Sledz C, Holko M, de Veer M, Silverman R, Williams B. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 2003; 5 (9): 834-9.
7. Sledz C, Williams B. RNA interference and double-stranded-RNAactivated pathways. Biochem Soc Trans 2004; 32 (Pt 6): 952-6.
8. Behlke MA. Progress towards in vivo use of siRNAs. Mol Ther 2006; 13: 644-70.
9. Li J, Liang Z. The consideration of synthetic short interfering RNA for therapeutic use. Basic Clin Pharmacol Toxicol 2007; 106(1): 22-9.
10. Moore MD, McGarvey MJ, Russell RA, Cullen BR, McClure MO. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors. J Gene Med 2005; 7(7): 918-25.
11. Trono D. Lentiviral vectors: Turning a deadly foe into a therapeutic agent. Gene Ther 2000; 7(1): 20-3.
12. Blomer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997; 71(9); 6641-9.
13. Trono, D., Zufferey, R.N. Methods and compositions relating to improved lentiviral vector production systems. US7629153 (2009).
14. Khaliq S, Khaliq SA, Zahur M, Ijaz B, Jahan S, Ansar M, et al. RNAi as a new therapeutic strategy against HCV. Biotechnol Adv 2010; 28(1); 27-34.
15. Wilson R, Purcell D, Netter HJ, Revill PA. Does RNA interference provide new hope for control of chronic hepatitis B infection? Antivir Ther 2009; 14(7): 879-89.
16. University of the Witwatersrand, Johannesburg. Primary micro RNA expression cassette. WO2010146251 (2010).
17. Kim, S.H. Arginine-conjugated bioreducible poly(disulfide) amine polymers for gene delivery system. US2010010067 (2010).
18. Kim SH, Jeong JH, Kim T, Kim SW, Bull DA. VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine). Mol Pharmaceutics 2009; 6 (3); 718-26.
19. Shemi, A. Methods, compositions and systems for local delivery of drugs. WO2010001325 (2010).
20. Dharmacon RNAi Technologies. Compositions and methods for mediating RNAi in vivo. US20100005317 (2010)
21. Haag, R., Fischer, W., Quadir, M.A., Satchi-Fainaro, R., Ofek, P. Compounds suited as nanocarriers for active agents and their use. WO2009141170 (2009).
22. Adib, A., Erbacher, P., Stock, F., Hafdi, N. Means for delivery of nucleic acids active for gene silencing using synthetic polymers. WO2009074970 (2009).
23. Ozpolat B, Sood AK, Lopez-Berestein G. Nanomedicine based approaches for the delivery of siRNA in cancer. J Int Med 2010; 267(1): 44-53.
24. Czech, M.P., Ostroff, G.R. Yeast cell wall protein (YCWP) encapsulated multilayered nanoparticles for nucleic acid delivery (SIRNA). W02009058913 (2009).
25. Akinc, A., Nakayama, T., Konys, D., Stoffel, M. Wolfrum, C. Compositions and methods for tissue specific RNAi delivery in vivo. WO2009120887 (2009).
26. Elmen, J., Wahlestedt, C. Liang, Z., Orum, H., Koch, T. New double stranded short interfering RNA analogs, useful for treating e.g. cancer and rheumatoid arthritis, comprised locked nucleic acid monomers. EP2141234 (2010).
27. Mirkov, T.E., Ingelbrecht, I.L. Isolation of proteins involved in post transcriptional gene silencing and methods of use. US7632937 (2009).
28. Turker, M. Methods of identifying inhibitors of gene silencing in mammalian cells. W02009154999 (2009).
29. Khvorova, A., Reynolds, A., Leake, D., Marshall, W., Read, S., Scaringe, S. siRNA targeting polo-like Kinase-1 (PLK-1). US20100004141 (2010).
30. Degenhardt Y, Lampkin T. Targeting Polo-like kinase in cancer therapy. Clin Cancer Res 2010; 16(2): 384-9.
31. Rubin EM, Guo Y, Tu K, Xie J, Zi X, Hoang BH. Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma. Mol Cancer Ther 2010; 9(3): 731-41.
32. Liang, Y., Biao, H., Xu, Z., Jablons, D.M. Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1). US7618936 (2009).
33. Khvorova, A., Leake, D., Marshall, W., Read, S., Scaringe, S. Reynolds, A. siRNA targeting proto-oncogene MET. US7608591 (2009)
34. Dharmacon RNAi Technologies. siRNA targeting cyclin-dependent kinase inhibitor. US7612196 (2009).
35. Khvorova, A., Reynolds, A., Leake, D., Marshall, W., Scaringe, S., Steven Read, S. http://www.freshpatents.com/Steven-Read- Boulder-invdirr.phpsiRNA targeting myeloid cell Leukemia sequence 1. US20100004142 (2010).
36. Freier, S.M.C., Bennett, F., Condon, T.P., Cleveland, D.W., Richard S.A. Methods for slowing familial ALS disease progression. US7622455 (2009).
37. Kaemmerer, W.F. Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA. US7618948 (2009).
38. Kaemmerer, W.F. Treatment of neurodegenerative disease through intracranial delivery of siRNA. US7605249 (2009).
39. Wang P, Liang Z, Zeng J, Li W, Sun X, Miao Z, et al. Generation of tobacco lines with widely different reduction in nicotine levels via RNA silencing approaches. J Biosci 2008 33(2):177-84.
40. Conkling, M.A. Song, W., Mendu, N. New isolated quinolate phosphoribosyl transferase obtained from Nicotiana tabacum, used for obtaining transgenic tobacco plants having reduced or increased levels of nicotine. US7605308 (2009).
41. Meli VS, Ghosh S, Prabha TN, Chakraborty N, Chakraborty S, Datta A. Enhancement of fruit shelf life by suppressing N-glycan processing enzymes. Proc Natl Acad Sci USA 2010; 107(6): 2413-8.
42. Fire, A., Kostas, S., Montgomery, M., Timmons, L., Xu, S., Tabara, H., Driver, S.E., Mello, C.C. Inhibiting expression of a target gene useful for altering fruit ripening characteristics. US7622633 (2009).
43. Atkinson HJ, Urwin PE, McPherson MJ. Engineering plants for nematode resistance. Ann Rev Phytopathol 2003; 41: 615-39.
44. Fairbairn DJ, Cavallaro AS, Bernard M, Mahalinga-Iyer J, Graham MW, Botella JR. Host-delivered RNAi: An effective strategy to silence genes in plant parasitic nematodes. Planta 2007; 226(6):1525-33.
45. Gheysen G, Vanholme B. RNAi from plants to nematodes. Trends Biotechnol 2007; 25(3):89-92.
46. Wiig, A. Compositions and methods using RNA interference for control of nematodes. US7622301 (2009).
47. Raemaekers, R., Kubler, L., Karel, G., Plaetinck, M., Vanbleu, E. New isolated double-stranded RNA molecules, useful for preventing insect infestation in plants or as active components in compositions for preventing or treating a human or animal body from infestation by insects. US20090285784 (2009).
48. Gressel, J., Al-ahmad, H. Novel methods and constructs for mitigating the introgression of genetically engineered crop traits to weeds comprising, e.g. producing apomictic seeds which give male sterile plants. US7612251 (2009).